New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.
/PRNewswire/ STORM Therapeutics Ltd. (STORM), the clinical biotechnology company discovering and developing novel small molecule therapies targeting RNA.
/PRNewswire/ Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 14th Annual.
DGAP-News: EBD Group / Key word(s): Conference Sixteenth Annual BIO-Europe Spring(R) Digital to bring together over 2,000 life science leaders 11.03.2022 / 10:00 The issuer is solely